Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetics of Afabicin in Renal Impairment
NCT07758608Phase 1Recruiting
- Sponsor
- Debiopharm
- Start
- Sep 2026
- Primary completion
- Dec 2027
- Countries
- 1
01
Overview
Phase 1, open-label trial of afabicin in bacterial infection (5 arms), sponsored by Debiopharm. Primary endpoint: Area Under the Plasma Concentration-Time Curve From Time Zero to Infinity. Started Sep 2026; status: recruiting.
02
Drugs
afabicin
03
Conditions
bacterial infection
Beyond the preview
Go deeper on NCT07758608.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07758608.